Overview
Local vaginal estrogen therapy is used to improve vaginal tissue health in women with estrogen deficiency. It can reduce symptoms of vaginal dryness, irritation, dyspareunia, and recurrent urinary symptoms. Systemic absorption is minimal at standard doses, making it a safe option for most women.
Indications
- Genitourinary Syndrome of Menopause (GSM)
- Vaginal dryness and atrophy
- Recurrent urinary tract infections
- Urinary urgency, frequency, and dysuria related to estrogen deficiency
- Adjunctive therapy with pessary use
Available Formulations
- Vaginal estradiol cream
- Vaginal estradiol tablets
- Estradiol vaginal ring (releases hormone slowly over three months)
- Conjugated estrogen cream
- Estriol cream (available in some regions)
How to Use
Treatment is typically initiated with more frequent application (usually daily for 2 weeks) and then transitioned to a maintenance schedule (usually twice weekly). Improvement may take several weeks to months to become apparent.
Safety
Local vaginal estrogen is generally considered safe, even for women with a history of breast cancer, after discussion with their primary care provider or oncologist. A progestin is not routinely required when using low-dose local vaginal estrogen in women with an intact uterus, though this should be discussed with your physician.
Important Considerations
- Benefits are maintained only with ongoing use — symptoms will recur when treatment is stopped
- Vaginal estrogen can be used in combination with other treatments (pessaries, PFMT)
- It does not provide the systemic benefits of hormone replacement therapy
Safety and Considerations
Low-dose vaginal estrogen therapy acts locally on vaginal tissues with minimal systemic absorption. All available preparations — creams, tablets, and rings — are equally effective. Current evidence has not shown an increased risk of cancer recurrence in women using vaginal estrogen who have a history of breast cancer. Side effects are uncommon and may include mild local irritation when starting treatment.
Illustrations courtesy of the International Urogynecological Association (IUGA) Patient Information Leaflets.